Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer

NCT01086605 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT01086605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of Two Doses of Pixantrone in Patients With Metastatic Breast Cancer
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
November 15, 2014
Enrollment
46 (actual)
Sites
230

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer